Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

3D Systems Corporation (DDD), Stratasys, Ltd. (SSYS): ExOne Co (XONE) Gets a Mulligan

Page 1 of 2

You know that golfing buddy that shanks his drive into the woods, only to nonchalantly re-tee another Pro V1 right before your eyes?  Effortlessly, he hits his mulligan–possibly in the woods again, or perhaps down the middle of the fairway.  But you don’t think anything of the do-over.  In the grand scheme of things, does it really matter?  One mulligan couldn’t cost you too much when it’s time to pay up….could it?

3D printer manufacturer ExOne Co (NASDAQ:XONE) is that golfing buddy.  The company recently missed revenue expectations by 16%, and whiffed on earnings by 82%.  Shares were crushed, down over 20% after the release.  But since then, the market has given ExOne Co (NASDAQ:XONE) a mulligan.  Shares have bounced back, and recently hit a new 52-week high.  Not bad for a company that sold exactly 5 printers in the quarter.  So why the mulligan?


Investment demand outpaces supply

The 3D printing, or additive manufacturing, industry is the talk of Wall Street and, increasingly, Main Street.  As discussed here, ExOne is the best pure-play 3D printing company focused solely on corporate customers, and not consumers.  ExOne Co (NASDAQ:XONE)’s market position in the explosive 3D printing industry, along with an outstanding management team, gives it the potential for a very bright future.

With limited options for 3D printing investments, investors wanting industry exposure are forced to choose between ExOne, 3D Systems Corporation (NYSE:DDD) and Stratasys, Ltd. (NASDAQ:SSYS). Since these three stocks make up the mainstream choices for industry investment, and simple supply and demand is working in the favor of all three companies.  The rising tide of industry sentiment is lifting all boats.

Currently there are no planned IPO’s, so the number of public 3D companies is likely to remain constant.  In fact, 3D Systems Corporation (NYSE:DDD) and Stratasys, Ltd. (NASDAQ:SSYS) are aggressively acquiring competitors, keeping new participants from the public market.  3D Systems seems to acquire a new company each quarter, and is the current market leader in revenue terms–for now.  Stratasys, Ltd. (NASDAQ:SSYS)’ 2012 merger with Objet created a viable competitor.  As both 3D Systems Corporation (NYSE:DDD) and Stratasys are able to issue stock as currency with minimal investor backlash, look for continued acquisitions in the industry and few 3D investing alternatives.

There simply aren’t enough additive manufacturing companies to invest in, and investors refuse to let one bad quarter blind the bright future of the industry.  So limited supply of investing choices in this hot industry is one reason ExOne Co (NASDAQ:XONE) was handed a mulligan.

One printer short

The average sale price of a Stratasys or 3D Systems machine is in the thousands of dollars.  These two companies put more emphasis on consumer-based sales, which mix at a lower unit rate per machine.  ExOne machines sold for a whopping $1.6 million apiece in the first quarter.  So the 5 machines that ExOne Co (NASDAQ:XONE) sold in the quarter amount to $7.9 million in revenue.  However, Wall Street analysts expected $9.2 million, which means that ExOne was one printer short of beating expectations.

Nobody expected ExOne to miss the quarterly revenue estimates.  Shares were punished and the company lost $100 million of enterprise value.  But the selling was too extreme when investors did the math and realized that ExOne Co (NASDAQ:XONE)’s shortfall was due to one printer not being sold.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!